Janina Niggenaber

7PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 14, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation.

Suzanne Willems, Lejla Maksumic, Janina Niggenaber

|Jan 03, 2024
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA.

A Teuber, T Schulz, B S Fletcher

|May 17, 2023
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines.

Tobias Grabe, Kirujan Jeyakumar, Janina Niggenaber

|Apr 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.

Jonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht

|Sep 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach.

Jonas Lategahn, Julia Hardick, Tobias Grabe

|Dec 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S.

Jonas Lategahn, Marina Keul, Philip Klövekorn

Pageof 2